Wegovy (semaglutide) is an FDA-approved medication designed to assist adults with the diagnoses of obesity or overweight, especially when accompanied by weight-related health issues. While its effectiveness is well-documented, understanding the process of qualification, administration, and maximizing benefits is crucial.
Wegovy belongs to a class of drugs known as GLP-1 receptor agonists. It mimics the glucagon-like peptide-1 hormone, which regulates appetite and food intake. By enhancing feelings of fullness and reducing hunger, it aids in calorie reduction and subsequent weight loss.
To be considered for a Wegovy prescription, you typically need to meet specific criteria.
Body mass index (BMI):
It’s essential to consult with a healthcare provider to assess individual health status and determine suitability for Wegovy.
Certain people should refrain from using Wegovy:
Always discuss medical history thoroughly with a healthcare provider before starting any new medication.
Insurance coverage for Wegovy varies:
It’s advisable to consult with insurance providers and explore patient assistance programs offered by the manufacturer.
Wegovy is administered via subcutaneous injection once weekly. Common injection sites include the abdomen, thigh, or upper arm. It’s crucial to rotate injection sites to prevent tissue damage.
Injection tips:
While Wegovy aids in weight reduction, combining it with lifestyle modifications enhances results:
Dietary changes:
Physical activity:
Behavioral strategies:
Structured programs like the Mayo Clinic Diet for Weight-Loss Medications offer valuable guidance, including personalized meal plans like Protein Balance for GLP-1s to support better outcomes while using medications such as Wegovy.
Common side effects include nausea, diarrhea, constipation, and abdominal discomfort. To mitigate these:
The Mayo Clinic Diet’s specialized meal plan is also designed to help minimize side effects by emphasizing higher protein intake and balanced nutrition, supporting better tolerance of GLP-1 medications.
If side effects persist or worsen, consult a healthcare provider.
To qualify for Wegovy, you must have a BMI of 30 or higher or a BMI of 27 or higher with at least one weight-related health condition. A thorough evaluation by a healthcare provider is essential to determine eligibility based on medical history and overall health status.
Open communication and demonstrating a proactive approach can aid in the discussion.
Coverage varies:
Out-of-pocket costs can be high; exploring manufacturer assistance programs is recommended.
For personalized guidance, additional resources, and structured support designed to enhance success with weight-loss medications, join the Mayo Clinic Diet and choose the Weight-Loss Medications program when you set up your account.
Success Stories (29) Food & Nutrition (17) Exercise (3) Habits & Motivation (10) Weight-Loss Medications (16)
Which plan is right for you?
Whether you're looking for a healthy weight-loss plan or considering weight-loss medication, discover which of our world-leading solutions is best for you.